Latest Breaking News On - Her2 positve breast cancer - Page 1 : comparemela.com

Nina D'Abreo, MD, discusses her presentation from an OncLive® State of the Science Summit™ on breast cancer, during which she discussed the treatment of patients with HER2-low and HER2-positive breast cancer.

Nina dabreoYork university grossman school of medicinePerlmutter cancer centerDepartment of medicineDivision of hematologyNinad abreoNew york university grossman schoolMedical oncologyScience summitRwjbarnabas health and rutgers cancer institute of new jerseyOnclive tvHer2 positve breast cancer